Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.18391 | 77 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.29829 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.99048 | 75 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.76394 | 73 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.76075 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.04047 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.33928 | 79 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.83664 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.76583 | 73 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.97543 | 75 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.17406 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.95992 | 75 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.88763 | 75 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.97614 | 75 |